Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · Real-Time Price · USD

0.9843

-0.0257 (-2.54%)

Sep 4, 2026, 8:20 AM EDT - Market open

Revelation Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.48	10.7	6.5	11.99	5.25	1.27
Cash & Short-Term Investments	11.48	10.7	6.5	11.99	5.25	1.27
Cash Growth	121.94%	64.64%	-45.80%	128.28%	312.09%	-71.63%
Prepaid Expenses	0.2	0.05	0.07	0.08	0.07	0.64
Other Current Assets	-	0.06	-	0.07	0.09	-
Total Current Assets	11.68	10.81	6.57	12.15	5.41	1.91
Property, Plant & Equipment	0.78	0.74	0.06	0.07	0.09	0.13
Other Long-Term Assets	0.03	0.03	-	-	-	-
Total Assets	12.5	11.58	6.62	12.21	5.5	2.04

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.93	0.58	0.78	1.36	0.55	0.6
Accrued Expenses	0.76	1.4	1.13	1.15	0.99	1.53
Current Portion of Leases	0.19	0.02	-	-	-	0.02
Other Current Liabilities	-	-	-	3.05	2.91	-
Total Current Liabilities	1.88	2	1.91	5.56	4.45	2.14
Long-Term Leases	0.55	0.72	-	-	-	-
Total Liabilities	2.43	2.72	1.91	5.56	4.45	2.14

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	65.81	58.28	45.21	32.11	26.4	14.42
Retained Earnings	-55.75	-49.42	-40.51	-25.47	-25.35	-14.52
Total Common Equity	10.07	8.86	4.71	6.65	1.05	-0.1
Shareholders' Equity	10.07	8.86	4.71	6.65	1.05	-0.1
Total Liabilities & Equity	12.5	11.58	6.62	12.21	5.5	2.04

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.74	0.75	-	-	-	0.02
Net Cash (Debt)	10.74	9.95	6.5	11.99	5.25	1.26
Net Cash Growth	107.64%	53.15%	-45.80%	128.28%	317.57%	-72.00%
Net Cash Per Share	4.65	16.03	454.70	-	-	-
Filing Date Shares Outstanding	3.98	3.72	0.08	-	-	-
Total Common Shares Outstanding	3.91	1.58	0.04	-	-	-
Working Capital	9.8	8.81	4.65	6.58	0.96	-0.23
Book Value Per Share	2.58	5.59	108.19	-	-	-
Tangible Book Value	10.07	8.86	4.71	6.65	1.05	-0.1
Tangible Book Value Per Share	2.58	5.59	108.19	-	-	-
Machinery	0.29	0.12	0.15	0.13	0.13	0.13

SEC Filings: 10-K · 10-Q